Gynac 2. Cancer Cervix

Question 1

Endocervix : -

1. Lies close to:-
2. Lined by :-
3. Colour :-

Answer 1

547

Question 2

Exocervix

1. Part of cervix that lies :-
2. Lined by :-
3. Colour :-

Answer 2

547

Question 3

External os :- 
Part where cervix :- 
Shape 
1. :- 
2. :-

Answer 3

547

Question 4

Transformation zone

1. Junction :-
2. Dynamic point : -
3. Lies at the level of :-

Trnaspformation zone movies outward ( toward cervix ) under 3 Ps

Moves inward when there’s no :-
I.e :-

Answer 4

547-548

Question 5

Classification of transformation zone :-
Type 1 :-
Type 2 :-
Type 3 :-

Colour :-

Answer 5

548

Question 6

Cancer cervix

MC cancer of cervix :-
MC site of cancer cervix :-
MC site of adenocarcinoma cervix :-

Answer 6

548

Question 7

Lymphatic drainage of cervix :- 
H
O
P
E 

MC LN involved in CA cervix :-
Sentinal LN for CA cervix :-
Superficial LN in CA cervix :-

Answer 7

548

Question 8

Pathogenesis of CA cervix

1. Metaplasia :-
2. Dysplasia :-

Classification of dysplasia 
CIN :- 
CIN 1 :- 
CIN 2 :- 
CIN 3 :- 
Cancer in situ :- 
Invasive cancer cervix :-

Answer 8

549

Question 9

Bethesda classification:-
CIN 1 :-

CIN 2 :-
CIN 3 :-
Cancer in situ :-

Note :- dysplastic cells :-

Answer 9

549

Question 10

Cancer cervix risk factor 
Most important :- 
Increase chances of inf in :- 
Other 
1. 
2. 
3. OCP causes :- 
4. Exposer to :-

Answer 10

550

Question 11

Human papilloma virus :-

3. Viral protein required
   a. For attachment:-
   b. For viral replication :-
   c. For malignancy:-

E6 :- suppresses :-
E7:- suppresses :-

Answer 11

551

Question 12

Diagnosis of HPV :- ,,,,,,,,,

3. ( best )

Done in female :-

Answer 12

551

Question 13

HPV subtypes :-

Answer 13

551

Question 14

One liner 
MC HPV associated with cancer cervix :- 
MC HPV associated with SCC of cervix :- 
Most specific HPV for CA cervix :- 
MC HPV asso with adenocarcinoma cervix :-

Answer 14

551

Question 15

Bivalent vaccine :- 
Brand :- 
HPV subtype :- 
Protect against:- 
Dosage schedule:- 
Route :- 
Administrated to :-
Adjuent :-

Answer 15

552

Question 16

Quadrivalent vaccine

Brand :- 
HPV subtype :- 
Protect against:- 
Dosage schedule:- 
Route :- 
Administrated to :-
Adjuent :-

Answer 16

552

Question 17

9 valent

Brand :- 
HPV subtype :- 
Protect against:- 
Dosage schedule:- 
Route :- 
Administrated to :-
Adjuent :-

Answer 17

552

Question 18

Age of vaccine administration:- 
Ideal age :- 
MC complication :- 
Contraindication 
1. 
2. 
3.

Answer 18

553

Question 19

MC age group of HPV inf :- 
MC sexually transmitted disease ( std ) in usa :- 
MC age for 
CIN :- 
Cancer in situ :- 
Cancer cervix :-

Answer 19

553

Question 20

Diagnosis of CA cervix :-

Screening test

3. Rural area :-

Diagnostic test :-
1.
2.

Answer 20

553

Question 21

Pap smear 
Age to start :- 
Instruments :- image 
1. 
2. 
Sample site 
Slide 1:-         To detect 
Slide 2 :-        To detect 
Slide 3 :-       From 

Images :-

Answer 21

554

Question 22

Sample site for cytology ( Pap smear ) :-
Sample site for hormone study :-

Fixative used in :-

Answer 22

555

Question 23

Liquid based cytology
1. Instrument:-
2. Ficpxative :-;
3.

Answer 23

555

Question 24

Guidelines for Pap smear :- 
1. Start pap smear at:- ,,,,,,,,,
    Repeat every :- 
    Till women becomes :- 
    From age ,,,,to ,,,yr of age :- ,,,,,,,,,l+ ,,,,,,,,
    Done every :-         
Or continue :-

Answer 24

556

Question 25

2. Stop Pap smear at :- ,,,,, years age Criteria to stop:- 1. :- 2.:- 3. HIV positive female :- Screening every :- Uncertain to stop :- 4. Female treated for Continue for :- 5. If female has taken HPV vaccine : :-

Answer 25

556

Question 26

VIA:- Dysplasia +ve colour : - Normal :-

Answer 26

556

Question 27

VILI Dysplasia +ve colour :- Unstained reason :- Normal :-

Answer 27

556

Question 28

``` Report or action of Pap smear :- Report 1 :- Report 2 :- Report 3 :- Report 4 :- Report 5 :- Report 6 :- Report 7 :- Report 8 :- ```

Answer 28

557

Question 29

``` Report 3 :- ,,,,,, Pap can detect inf 1. 2. 3. 4. 5. Pap smear can not detect :- 1. 2. ```

Answer 29

557

Question 30

Report 4 :- ASCUS :- % ,,,,,to convert in ,,,,,,, 1. Age 21-24 :- ,,,,,,,, 2. Age > 25 :-

Answer 30

557

Question 31

Report 5 :- LSIL 1. :- 2. :- In case of HSIL :- growth not visible :-

Answer 31

558

Question 32

LSIL in female ( 21-24 ) :- Follow up with :- Contraindicated:- LSIL in post menopausal :- 1. 2. 3. LSIL in pregnant female :- In HSIL :-

Answer 32

558

Question 33

Other report and action of Pap smear :- 1. Pap :- normal , but HPV DNA is positive :- Repeat:- Persist Do :-

Answer 33

559

Question 34

Report 6 :- % of conversion :- HPE cannot exclude :- Do :-

Answer 34

559

Question 35

Report 7 Lesion visible :- Lesion not visible :-

Answer 35

559

Question 36

Report 8 :- Suggest :- Test done :-

Answer 36

559